Peroxisome proliferator-activated receptor γ (PPARγ) ligands as bifunctional regulators of cell proliferation (Q35557575)

8 August 2017

1 reference

title

Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation (English)

1 reference

8 August 2017

Peroxisome proliferator-activated receptor γ (PPARγ) ligands as bifunctional regulators of cell proliferation (English)

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00488-X

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00488-X

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00488-X

20 March 2024

2

Young-Joon Surh

1 reference

8 August 2017

Hye-Kyung Na

1

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

8 August 2017

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14555212

full work available at URL

20 March 2024

https://api.elsevier.com/content/article/PII:S000629520300488X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00488-X

https://api.elsevier.com/content/article/PII:S000629520300488X?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00488-X

20 March 2024

published in

Biochemical Pharmacology

1 reference

8 August 2017

66

1 reference

8 August 2017

1381-1391

1 reference

8 August 2017

8

1 reference

The production of prostanoids in human cancers, and their implications for tumor progression

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Cyclopentenone prostaglandins: new insights on biological activities and cellular targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Roles of PPARs in health and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Terminal differentiation of human breast cancer through PPAR gamma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

15-Deoxy-Delta(12,14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: oxidative stress-induced extracellular signal-regulated kinase activation without NF-kappa B inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive ox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

The nature and composition of 15-deoxy-Delta(12,14)PGJ(2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by peroxisome proliferator-activated receptor gamma activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Induction of glutathione S-transferase by prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Antioxidants and oxidants regulated signal transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Induction of cellular antioxidative stress genes through heterodimeric transcription factor Nrf2/small Maf by antirheumatic gold(I) compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Identification of a variant antioxidant response element in the promoter of the human glutamate-cysteine ligase modifier subunit gene. Revision of the ARE consensus sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Involvement of protein kinase in delta 12-prostaglandin J2-induced expression of rat heme oxygenase-1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Aspirin and the Risk of Colorectal Cancer in Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. A cyclooxygenase-2 mediated pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

New insights into the role of COX 2 in inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Induction of cyclooxygenase-2 in Ras-transformed human mammary epithelial cells undergoing apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Formation of thiol conjugates of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900488-X

Aspirin and the potential role of prostaglandins in colon cancer

7 January 2021

2

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00488-X

Peroxisome proliferator-activated receptors: nuclear control of metabolism

20 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00488-X

15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors.

20 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00488-X

Feedback control of cyclooxygenase-2 expression through PPARgamma

20 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00488-X

Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder

20 March 2024

72

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00488-X

The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention

20 March 2024

75

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00488-X

20 March 2024

Identifiers

1 reference

8 August 2017

1 reference